Analytical Data
-
基因名
OTUD6B
- Application
-
别名
ubiquitinyl hydrolase 1; OTUD6B; Homo sapiens; Human; 3.4.19.12
-
种属
Human
-
表达系统
E. coli
-
标签
Flag
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
A0A087X0W9
-
表达区间
E2-S323
-
蛋白长度
Full Length of Mature Protein
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
OTUD6B (OTU deubiquitinating enzyme 6B) is a member of the OTU subfamily of deubiquitinating enzymes, which play critical roles in various cellular processes by removing ubiquitin from proteins, thereby regulating their stability, localization, and function. Research on OTUD6B has gained prominence due to its involvement in several biological pathways, including cell cycle regulation, DNA repair, and immune response, making it a potential target for therapeutic interventions. Dysregulation of OTUD6B has been linked to various diseases, including cancer, where altered ubiquitination can lead to abnormal protein function and tumorigenesis. Recent studies have highlighted its role in modulating key signaling pathways, further emphasizing its importance in cellular homeostasis. Given the increasing interest in the ubiquitin-proteasome system as a therapeutic target, understanding the functional mechanisms of OTUD6B and characterizing its recombinant protein is crucial for elucidating its biological significance and potential for drug development. Investigating OTUD6B's interactions with other cellular components may provide insights into its precise role in disease contexts and unveil novel strategies for targeting related pathways in clinical settings. As such, the study of OTUD6B recombinant protein is not only fundamental for basic biology but also bears significant implications for therapeutic advancements in human health.












